Citing potential disclosure requirements from the Food and Drug Administration, lack of insurance coverage and lack of support among clinicians, the founders of stool-donation initiative, OpenBiome, ...

Working in the hospital again always provides valuable perspective. I love (most of) the patient care, and seeing differences in patterns over time, as I only see patients episodically. One of the ...

C. diff, which is short for Clostridioides difficile, is a type of bacteria that may cause serious problems in the digestive system. It is one of the most common causes of diarrhea linked to ...

EINPresswire/ -- Faex Health, a fast-growing digital health startup, today announced the release of its C. difficile (C. diff) detection feature, making it one of the first AI platforms to screen for ...

Clostridium difficile bacteria, computer illustration. C. difficile is a normal inhabitant of the human intestine, but it can become a pathogen when antibiotics disrupt the normal intestinal flora and ...

Q: I was sick for months with debilitating pain, extreme weight loss, fatigue and loss of appetite. I was diagnosed with C. diff related to an abdominal surgery. I’m being treated with antibiotics, ...

Costly treatments from Merck & Co and other drugmakers, and a vaccine from Sanofi, are on the horizon. But growing numbers of gastroenterologists are more excited about the use of human stool ...

Fecal microbiota transplantation has become one of the most effective treatments for recurrent Clostridioides difficile infections, but its long-term role in gastroenterology may hinge on moving ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PHILADELPHIA -- ...